|
1
|
Gaio DS, Schmidt MI, Duncan BB, et al:
Hypertensive disorders in pregnancy: Frequency and associated
factors in a cohort of Brazilian women. Hypertens Pregnancy.
20:269–281. 2001. View Article : Google Scholar
|
|
2
|
Lykke JA, Langhoff-Roos J, Sibai BM, et
al: Hypertensive pregnancy disorders and subsequent cardiovascular
morbidity and type 2 diabetes mellitus in the mother. Hypertension.
53:944–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nahar L, Nahar K, Hossain MI, Jahan S and
Rahman MM: Placental changes in pregnancy induced hypertension.
Mymensingh Med J. 22:684–693. 2013.PubMed/NCBI
|
|
4
|
Nahar L, Nahar K, Hossain MI, Yasmin H and
Annur BM: Placental changes in pregnancy induced hypertension and
its impacts on fetal outcome. Mymensingh Med J. 24:9–17.
2015.PubMed/NCBI
|
|
5
|
LaMarca B, Cornelius D and Wallace K:
Elucidating immune mechanisms causing hypertension during
pregnancy. Physiology (Bethesda). 28:225–233. 2013.
|
|
6
|
Cao X, Wang LL and Luo X: Expression of
regulatory T and helper T cells in peripheral blood of patients
with pregnancy-induced hypertension. Clin Exp Obstet Gynecol.
40:502–504. 2013.PubMed/NCBI
|
|
7
|
Kalkunte SS, Mselle TF, Norris WE, et al:
Vascular endothelial growth factor C facilitates immune tolerance
and endovascular activity of human uterine NK cells at the
maternal-fetal interface. J Immunol. 182:4085–4092. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tripathi R, Ralhan R, Saxena S, et al:
Soluble VEGFR-1 in pathophysiology of pregnancies complicated by
hypertensive disorders: The Indian scenario. J Human Hypertens.
27:107–114. 2012. View Article : Google Scholar
|
|
9
|
Geissmann F, Auffray C, Palframan R, et
al: Blood monocytes: Distinct subsets, how they relate to dendritic
cells and their possible roles in the regulation of T-cell
responses. Immunol Cell Biol. 86:398–408. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van de Laar L, Buitenhuis M, Wensveen FM,
et al: Human CD34-derived myeloid dendritic cell development
requires intact phosphatidylinositol 3-kinase-protein kinase
B-mammalian target of rapamycin signaling. J Immunol.
184:6600–6611. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Laxmanan S, Robertson SW, Wang E, et al:
Vascular endothelial growth factor impairs the functional ability
of dendritic cells through Id pathways. Biochem Biophys Res Comm.
334:193–198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oyama T, Ran S, Ishida T, et al: Vascular
endothelial growth factor affects dendritic cell maturation through
the inhibition of nuclear factor-kappa B activation in hemopoietic
progenitor cells. J Immunol. 160:1224–1232. 1998.PubMed/NCBI
|
|
13
|
Seetharam L, Gotoh N, Maru Y, et al: A
unique signal transduction from FLT tyrosine kinase, a receptor for
vascular endothelial growth factor VEGF. Oncogene. 10:135–147.
1995.PubMed/NCBI
|
|
14
|
Schonkeren D, van der Hoorn ML, Khedoe P,
et al: Differential distribution and phenotype of decidual
macrophages in preeclamptic versus control pregnancies. Am J
Pathol. 178:709–717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stober D, Schirmbeck R and Reimann J:
IL-12/IL-18-dependent IFN-γ release by murine dendritic cells. J
Immunol. 167:957–965. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Block MS, Nevala WK, Leontovich AA, et al:
Differential response of human and mouse dendritic cells to VEGF
determines interspecies discrepancies in tumor-mediated TH1/TH2
polarity shift. Clin Cancer Res. 17:1776–1783. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Z, Varney ML, Backora MW, et al:
Down-regulation of vascular endothelial cell growth factor-C
expression using small interfering RNA vectors in mammary tumors
inhibits tumor lymphangiogenesis and spontaneous metastasis and
enhances survival. Cancer Res. 65:9004–9011. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vicari AP, Treilleux I and Lebecque S:
Regulation of the trafficking of tumour-infiltrating dendritic
cells by chemokines. Semin Cancer Biol. 14:161–169. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berger S, Dyugovskaya L, Polyakov A, et
al: Short-term fibronectin treatment induces endothelial-like and
angiogenic properties in monocyte-derived immature dendritic cells:
involvement of intracellular VEGF and MAPK regulation. Eur J Cell
Biol. 91:640–653. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mahnke K, Schmitt E, Bonifaz L, et al:
Immature, but not inactive: The tolerogenic function of immature
dendritic cells. Immunol Cell Biol. 80:477–483. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sugiyama M, Kakeji Y, Tsujitani S, et al:
Antagonism of VEGF by genetically engineered dendritic cells is
essential to induce antitumor immunity against malignant ascites.
Mol Cancer Ther. 10:540–549. 2011. View Article : Google Scholar : PubMed/NCBI
|
